A Yakima County resident exposed to infected dairy cattle has died of avian influenza. A third human case has also been confirmed as H5N1 spreads to 33 herds in the county.
|Articles|May 11, 2020
Contagion Live News Network: Epidemic Risks of Industrial Farming & More
Author(s)Grant M. Gallagher
A brief summary of our daily coverage.
Advertisement
Hello and thanks for joining me. I’m assistant editor Grant Gallagher. I’ll be giving a quick summary of our recent coverage on Contagion.
In our coverage today, we examined how current methods of industrial farming and agriculture increase the risk for epidemics.
We also discussed the fact that some medical journal editors are calling for managed expectations about the numerous clinical trials that will soon release results on potential coronavirus treatments. Close scrutiny will be necessary to parse through the new information.
We also featured an interview with Dr. William Schafner, who gave an overlay of the vaccine landscape that’s in development for COVID-19.
Tomorrow, we’ll be talking about the use of PrEP to prevent HIV transmission among at-risk teens, among other stories, so be sure to stay tuned.
For Contagion, I’m Grant. Thanks for joining us.
Advertisement
Related to this article
Voceryq earned FDA accelerated approval for adults with RRP after 7 of 26 patients (27%) needed no surgery for 12 months in RRP-001; a confirmatory trial is required.
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Investigational agent Zelicapavir cut time to complete RSV symptom resolution by up to a week and lowered hospitalization in high-risk adults.
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Oral zelicapavir cut time to complete RSV symptom resolution by up to 1 week in high-risk adults, but it did not meet its primary end point in a phase 2 trial.
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 30% of US Adults Report Misrepresenting Symptoms to Get Antibiotics
2
FDA Tentatively Approves First Generic Lenacapavir PrEP for 120 LMICs
3
Washington State Reports First US Avian Influenza Death of 2026
4
Postapproval Surveillance Confirms Ceftobiprole Activity Against MRSA
5